We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Learn more OK
Roche Menu Search Global Web Site : Products

You are here:

  1. Products
  2. Product list
Roche Language: DE
  • Home
  • About Roche
  • Sustainability
  • Research & Development
  • Partnering
  • Media
  • Investors
  • Careers
  • Products
  • Pharmaceuticals
  • Solutions for Diagnostics
  • Products for Researchers

Tamiflu (oseltamivir)

Tamiflu is licensed for the treatment of influenza in adults and children, and the prevention of influenza in adults and children one year of age and older. Tamiflu is an oral neuraminidase inhibitor (NAI) that acts by stopping the influenza virus from spreading and is active at sites in the body where the virus multiplies.

A
  • Actemra/RoActemra (tocilizumab)
  • Alecensa (alectinib)
  • Avastin (bevacizumab)
C
  • CellCept (mycophenolate mofetil)
  • Copegus (ribavarin)
  • Cotellic (cobimetinib)
E
  • Enspryng (satralizumab)
  • Erivedge (vismodegib)
  • Esbriet (pirfenidone)
  • Evrysdi (risdiplam)
F
  • Fuzeon (enfuvirtide)
G
  • Gazyva/Gazyvaro (obinutuzumab)
H
  • Hemlibra (emicizumab)
  • Herceptin (trastuzumab)
  • Herceptin SC / Herceptin Hylecta (trastuzumab hyaluronidase)
K
  • Kadcyla (trastuzumab emtansine)
M
  • MabThera / Rituxan (rituximab)
  • MabThera SC / Rituxan Hycela (rituximab hyaluronidase)
  • Madopar (levodopa benserazide)
  • Mircera (methoxy polyethylene glycol epoetin beta)
N
  • NeoRecormon (epoetin beta)
O
  • Ocrevus (ocrelizumab)
P
  • Pegasys (peginterferon α)
  • Perjeta (pertuzumab)
  • Phesgo (pertuzumab trastuzumab hyaluronidase)
  • Polivy (polatuzumab vedotin)
  • Pulmozyme (dornase alfa)
R
  • Roaccutane/Accutane (isotretinoin)
  • Rocephin (ceftriaxone)
  • Rozlytrek (entrectinib)
T
  • Tamiflu (oseltamivir)
  • Tarceva (erlotinib)
  • Tecentriq (atezolizumab)
V
  • Valcyte (valganciclovir)
X
  • Xeloda (capecitabine)
  • Xofluza (baloxavir marboxil)
Z
  • Zelboraf (vemurafenib)

Our global pharmaceutical product portfolio

Products A-Z

Disease areas

Products for Researchers

Solutions for Diagnostics

  • © 2021 F. Hoffmann-La Roche Ltd
  • 20.04.2021
  • Legal Statement
  • Privacy Policy
  • Cookie Settings

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

  • LinkedIn
  • Facebook
  • Pinterest
  • Twitter
  • YouTube